T

TransChromix LLC

BiotechChapel HillGrant

Chapel Hill therapeutics company developing brain-penetrant small molecules for Alzheimer's disease and other conditions using chromatin-activity-based chemoproteomics.

At a glance

  • HQ: Chapel Hill
  • Sector: Biotech
  • Stage: Grant
  • Affiliation: UNC

The rest of this record is behind a free account.

Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.